A detailed history of Bailard, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bailard, Inc. holds 15,197 shares of BMY stock, worth $823,373. This represents 0.02% of its overall portfolio holdings.

Number of Shares
15,197
Previous 15,159 0.25%
Holding current value
$823,373
Previous $822,000 23.24%
% of portfolio
0.02%
Previous 0.02%

Shares

38 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$40.25 - $52.99 $1,529 - $2,013
38 Added 0.25%
15,197 $631,000
Q1 2024

May 08, 2024

SELL
$47.98 - $54.4 $23,510 - $26,656
-490 Reduced 3.13%
15,159 $822,000
Q4 2023

Feb 02, 2024

SELL
$48.48 - $57.85 $7.87 Million - $9.39 Million
-162,366 Reduced 91.21%
15,649 $802,000
Q3 2023

Oct 24, 2023

BUY
$57.89 - $64.73 $37,049 - $41,427
640 Added 0.36%
178,015 $10.3 Million
Q2 2023

Jul 20, 2023

SELL
$63.71 - $70.74 $3.27 Million - $3.63 Million
-51,367 Reduced 22.46%
177,375 $11.3 Million
Q1 2023

May 08, 2023

BUY
$65.71 - $74.53 $278,019 - $315,336
4,231 Added 1.88%
228,742 $15.9 Million
Q4 2022

Feb 02, 2023

BUY
$68.48 - $81.09 $122,510 - $145,070
1,789 Added 0.8%
224,511 $16.2 Million
Q3 2022

Oct 18, 2022

BUY
$0.13 - $76.84 $717 - $424,387
5,523 Added 2.54%
222,722 $15.8 Million
Q2 2022

Jul 27, 2022

SELL
$72.62 - $79.98 $148,725 - $163,799
-2,048 Reduced 0.93%
217,199 $16.7 Million
Q1 2022

Apr 25, 2022

BUY
$61.48 - $73.72 $288,833 - $346,336
4,698 Added 2.19%
219,247 $16 Million
Q4 2021

Feb 10, 2022

SELL
$53.63 - $62.52 $7,132 - $8,315
-133 Reduced 0.06%
214,549 $13.4 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $157,392 - $184,364
-2,660 Reduced 1.22%
214,682 $12.7 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $77,201 - $84,072
-1,247 Reduced 0.57%
217,342 $14.5 Million
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $3.46 Million - $3.9 Million
58,370 Added 36.43%
218,589 $13.8 Million
Q4 2020

Feb 03, 2021

BUY
$57.74 - $65.43 $32,854 - $37,229
569 Added 0.36%
160,219 $9.94 Million
Q3 2020

Nov 10, 2020

SELL
$57.43 - $63.64 $171,371 - $189,901
-2,984 Reduced 1.83%
159,650 $9.63 Million
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $416,686 - $487,148
7,601 Added 4.9%
162,634 $9.56 Million
Q1 2020

Apr 16, 2020

BUY
$46.4 - $67.43 $384,563 - $558,859
8,288 Added 5.65%
155,033 $8.64 Million
Q4 2019

Jan 31, 2020

BUY
$49.21 - $64.19 $1.81 Million - $2.36 Million
36,834 Added 33.51%
146,745 $9.42 Million
Q3 2019

Oct 18, 2019

SELL
$42.77 - $50.71 $2,737 - $3,245
-64 Reduced 0.06%
109,911 $5.57 Million
Q2 2019

Jul 26, 2019

BUY
$44.62 - $49.34 $2.54 Million - $2.81 Million
57,021 Added 107.68%
109,975 $4.99 Million
Q1 2019

Apr 24, 2019

BUY
$45.12 - $53.8 $226,141 - $269,645
5,012 Added 10.45%
52,954 $2.53 Million
Q4 2018

Feb 05, 2019

SELL
$48.76 - $63.23 $690,734 - $895,716
-14,166 Reduced 22.81%
47,942 $2.49 Million
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $265,795 - $299,796
-4,816 Reduced 7.2%
62,108 $3.86 Million
Q2 2018

Aug 08, 2018

BUY
$50.53 - $62.98 $12,076 - $15,052
239 Added 0.36%
66,924 $3.7 Million
Q1 2018

May 07, 2018

BUY
$59.92 - $68.98 $69,327 - $79,809
1,157 Added 1.77%
66,685 $4.22 Million
Q4 2017

Feb 08, 2018

BUY
$59.94 - $65.35 $84,815 - $92,470
1,415 Added 2.21%
65,528 $0
Q3 2017

Oct 11, 2017

BUY
$55.23 - $63.74 $2.37 Million - $2.73 Million
42,823 Added 201.14%
64,113 $4.09 Million
Q2 2017

Aug 11, 2017

SELL
N/A
-776 Reduced 3.52%
21,290 $0
Q1 2017

Jan 29, 2018

BUY
N/A
326 Added 1.5%
22,066 $1.2 Million
Q4 2016

Jan 29, 2018

BUY
N/A
2,152 Added 10.99%
21,740 $0
Q3 2016

Jan 29, 2018

SELL
N/A
-446 Reduced 2.23%
19,588 $1.06 Million
Q2 2016

Jan 29, 2018

BUY
N/A
1,436 Added 7.72%
20,034 $0
Q1 2016

Jan 29, 2018

SELL
N/A
-971 Reduced 4.96%
18,598 $1.19 Million
Q3 2015

Jan 29, 2018

SELL
N/A
-1,575 Reduced 7.45%
19,569 $1.16 Million
Q2 2015

Jan 29, 2018

SELL
N/A
-3,758 Reduced 15.09%
21,144 $0
Q1 2015

Jan 29, 2018

SELL
N/A
-1,150 Reduced 4.41%
24,902 $1.61 Million
Q4 2014

Jan 29, 2018

BUY
N/A
26,052
26,052 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bailard, Inc. Portfolio

Follow Bailard, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.